See more : Concord Acquisition Corp (CNDAW) Income Statement Analysis – Financial Results
Complete financial analysis of Medical Data Vision Co., Ltd. (3902.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medical Data Vision Co., Ltd., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Partners Value Investments LP (PVVLF) Income Statement Analysis – Financial Results
- Rane (Madras) Limited (RML.NS) Income Statement Analysis – Financial Results
- Sterling and Wilson Renewable Energy Limited (SWSOLAR.NS) Income Statement Analysis – Financial Results
- Immuron Limited (IMRN) Income Statement Analysis – Financial Results
- Helium Evolution Incorporated (HEEVF) Income Statement Analysis – Financial Results
Medical Data Vision Co., Ltd. (3902.T)
About Medical Data Vision Co., Ltd.
Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company also offers medical data analysis, survey, and consulting services; management consulting services for medical institutions; and medical data services, as well as plans, designs, develops, and operates portal sites. It provides its services to pharmaceutical companies, medical device manufacturer, academia, research institution, and health insurance providers. The company was founded in 2003 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.42B | 6.10B | 5.67B | 4.58B | 4.03B | 3.58B | 3.23B | 2.63B | 2.41B | 1.95B | 1.53B |
| Cost of Revenue | 1.39B | 1.07B | 1.03B | 697.30M | 662.20M | 797.71M | 619.66M | 458.07M | 516.38M | 384.92M | 288.34M |
| Gross Profit | 5.03B | 5.03B | 4.64B | 3.88B | 3.36B | 2.78B | 2.61B | 2.17B | 1.90B | 1.57B | 1.24B |
| Gross Profit Ratio | 78.38% | 82.40% | 81.87% | 84.77% | 83.55% | 77.70% | 80.79% | 82.60% | 78.61% | 80.27% | 81.16% |
| Research & Development | 68.18M | 332.99M | 316.64M | 113.08M | 21.68M | 955.00K | 6.26M | 16.28M | 6.15M | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.19B | 2.94B | 2.73B | 2.62B | 2.53B | 2.43B | 2.03B | 1.73B | 1.57B | 0.00 | 0.00 |
| Other Expenses | 0.00 | 3.27B | 3.05B | 2.74B | 2.55B | -2.00K | 238.00K | -12.76M | 131.00K | -11.78M | 748.00K |
| Operating Expenses | 3.26B | 3.27B | 3.05B | 2.74B | 2.55B | 2.43B | 2.04B | 1.74B | 1.61B | 1.31B | 1.03B |
| Cost & Expenses | 4.65B | 4.35B | 4.08B | 3.43B | 3.22B | 3.23B | 2.66B | 2.20B | 2.13B | 1.69B | 1.32B |
| Interest Income | 62.00K | 157.00K | 30.00K | 22.00K | 205.00K | 267.00K | 163.00K | 189.00K | 256.00K | 168.00K | 131.00K |
| Interest Expense | 0.00 | 641.71M | 0.00 | 0.00 | 43.00K | 9.00K | 1.96M | 25.00K | 36.00K | 122.00K | 61.00K |
| Depreciation & Amortization | 102.02M | 149.99M | 135.55M | 158.80M | 180.87M | 169.91M | 133.22M | 96.54M | 75.37M | 72.12M | 55.30M |
| EBITDA | 1.87B | 1.91B | 1.73B | 1.24B | 838.81M | 484.91M | 682.49M | 390.38M | 357.15M | 317.39M | 265.04M |
| EBITDA Ratio | 29.16% | 36.56% | 30.50% | 30.06% | 24.60% | 14.59% | 21.63% | 19.36% | 14.73% | 16.45% | 17.39% |
| Operating Income | 1.77B | 1.76B | 1.59B | 1.15B | 809.61M | 351.62M | 569.09M | 430.95M | 282.49M | 260.59M | 209.74M |
| Operating Income Ratio | 27.59% | 28.80% | 28.11% | 25.03% | 20.11% | 9.83% | 17.64% | 16.37% | 11.70% | 13.36% | 13.70% |
| Total Other Income/Expenses | -203.00M | -331.47M | -2.32M | -69.80M | -151.71M | -36.63M | -21.78M | -137.11M | -20.11M | -16.21M | -308.00K |
| Income Before Tax | 1.57B | 1.43B | 1.59B | 1.08B | 657.90M | 314.99M | 547.31M | 293.84M | 262.39M | 244.37M | 209.43M |
| Income Before Tax Ratio | 24.43% | 23.37% | 28.06% | 23.51% | 16.34% | 8.80% | 16.97% | 11.16% | 10.87% | 12.53% | 13.68% |
| Income Tax Expense | 613.62M | 569.52M | 491.86M | 374.08M | 112.25M | 253.59M | 192.71M | 115.63M | 98.38M | 108.91M | 4.50M |
| Net Income | 979.13M | 870.51M | 1.09B | 700.22M | 554.32M | 69.47M | 354.60M | 178.21M | 164.01M | 135.46M | 204.93M |
| Net Income Ratio | 15.25% | 14.26% | 19.17% | 15.29% | 13.77% | 1.94% | 10.99% | 6.77% | 6.79% | 6.94% | 13.39% |
| EPS | 25.63 | 22.77 | 27.74 | 17.72 | 13.85 | 1.74 | 8.86 | 4.67 | 4.42 | 4.51 | 7.08 |
| EPS Diluted | 25.63 | 22.76 | 27.74 | 17.72 | 13.85 | 1.74 | 8.86 | 4.47 | 4.19 | 4.08 | 7.08 |
| Weighted Avg Shares Out | 38.20M | 38.23M | 39.19M | 39.51M | 40.03M | 40.02M | 40.01M | 38.16M | 37.14M | 30.05M | 28.96M |
| Weighted Avg Shares Out (Dil) | 38.20M | 38.23M | 39.19M | 39.51M | 40.03M | 40.02M | 40.01M | 39.82M | 39.17M | 33.18M | 28.96M |
Source: https://incomestatements.info
Category: Stock Reports